WST NYSE
West Pharmaceutical Services, Inc.
1W: +2.4%
1M: +6.0%
3M: +18.0%
YTD: +44.2%
1Y: +34.0%
3Y: +10.2%
5Y: -3.6%
$398.29
+3.56 (+0.90%)
Weekly Expected Move ±2.9%
$370
$381
$392
$403
$415
Credit Risk of going bust: lower than 93% of companies Debt: 1.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.34 (down 99.9%), West Pharmaceutical Services, Inc. would be worth roughly what it owes.
Total debt $312.1M against a stock market value of $28.03B.
Distance to default 16.53 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $166.5M (short-term plus half of long-term), stock volatility 31.2%; Altman Z 18.79. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.34 (down 99.9%), West Pharmaceutical Services, Inc. would be worth roughly what it owes.
Total debt $312.1M against a stock market value of $28.03B.
Distance to default 16.53 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $166.5M (short-term plus half of long-term), stock volatility 31.2%; Altman Z 18.79. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
1 relationships1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2023-11-30
Earliest Filing
2023-11-30
Latest Filing
supplier: 1
Counterparties (Filed by WST)
1 relationshipsCompanies named in WST's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| ExxonMobil Product Solutions Company | — | supplier | Agreed to supply butyl polymers to West Pharmaceutical Services, Inc. | 2023-11-30 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-26 | Material Agreement; Termination of Agreement; Financial Obligation; Exhibits | Agreement | View |
| 2026-07-23 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-07-14 | Material Agreement; Exhibits | Agreement | View |
| 2026-06-01 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-05-20 | Exhibits | View | |
| 2026-05-11 | Regulation FD; Exhibits | View | |
| 2026-05-05 | Shareholder Vote; Exhibits | View | |
| 2026-04-23 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-03-09 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2026-02-12 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-10-23 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-09-11 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-07-24 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-07-21 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-05-12 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-05-08 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2025-04-24 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-04-24 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-04-14 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-03-11 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR